Survodutide - Novel Anti Obesity Drug

Survodutide - Novel Anti Obesity Drug

Survodutide (BI 456906) is a novel, dual agonist of glucagon and glucagon-like peptide-1 (GLP-1) receptors developed as a once-weekly subcutaneous injection for the management of obesity. While GLP-1 receptor agonists have shown promise in managing obesity and associated complications, survodutide...

Full description

Saved in:
Bibliographic Details
Main Authors: Irtiqa Ayani Rathore, Sana Malik, Amarjeet Singh, Vishal R Tandon, Annil Mahajan
Format: Article
Language:English
Published: Dr. Annil Mahajan 2025-01-01
Series:JK Science
Subjects:
Survodutide
Obesity
Online Access:https://journal.jkscience.org/index.php/JK-Science/article/view/344
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items